Patent · US5378696A · A · US
Rapamycin esters
- (11) Publication number
- US5378696A
- (21) Application number
- US-7385793-A
- (22) Filing date
- 1993-06-08
- (30) Priority date
- 1990-09-19
- (43) Publication date
- 1995-01-03
- (45) Date of grant
- 1995-01-03
- (52) CPC
- (73) Assignee
- AMERICAN HOME PROD
- (54) Title
- Rapamycin esters
- (57) Abstract
A compound of the structure ##STR1## wherein R 1, R 2, and R 3 are each, independently, hydrogen or ##STR2## with the proviso that R 1, R 2, and R 3 are not all hydrogen; R 4 is --(CH 2) m X(CH 2) n CO 2 R 5 or ##STR3## R 5 and R 6 are each, independently, hydrogen, alkyl, alkenyl, alkynyl, (CH 2) p NR 9 R 10, mono-, di-, or tri-hydroxyalkyl, aralkyl, or aryl; ##STR4## R 7, R 8, R 9, and R 10 are each, independently, hydrogen or alkyl; Y is CH or N: m is 0-4; n is 0-4; p is 0-4; with the proviso that m and n are not both 0 when X is O or S; or a pharmaceutically acceptable salt thereof, which is by virtue of its immunosuppressive activity is useful in treating transplantation rejection, host vs. graft disease, autoimmune diseases, and diseases of inflammation, by virtue of its antitumor activity useful in treating tumors, and by virtue of its antifungal activity is useful in treating fungal infections.
- Full text
- View on Google Patents
Claims (6)
- A compound of the structure ##STR10## wherein R 1, R 2, and R 3 are each, independently, hydrogen or ##STR11## with the proviso that R 1, R 2, and R 3 are not all hydrogen; R 4 is --(CH 2) m X(CH 2) n CO 2 R 5 or ##STR12## R 5 and R 6 are each, independently, hydrogen, alkenyl of 2-7 carbon atoms, alkynyl of 2-7 carbon atoms, (CH 2) p NR 9 R 10, mono-, di-, or tri-hydroxyalkyl of 1-8 carbon atoms, or aryl, which is optionally mono-, di-, or tri- substituted with a group selected from alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms of which the alkyl group is of 1-4 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, hydroxy, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, dialkylamino of 1-6 carbon atoms per alkyl group, dialkylaminoalkyl of 3-12 carbon atoms, hydroxyalkyl of 1-6 carbon atoms, alkoxyalkyl of 2-12 carbon atoms, and alkylthio of 1-6 carbon atoms, wherein the above aryl group is selected from phenyl, pyridinyl, thienyl, furyl, isoxazolyl, thiazolyl, imidazolyl, pyrazinyl, pyrimidinyl, benzofuryl, benzoxazolyl, benzoisoxazolyl, benzthiazolyl, benimidazolyl, indolyl, quinolyl, isoquinolyl, thianaphthyl and benzopyranyl; X is ##STR13## R 7, R 8, R 9, and R 10 are each, independently, hydrogen or alkyl of 1-6 carbon atoms: Y is CH or N: m is 0-4; n is 0-4: p is 0-4; with the proviso that m and n are not both 0 when X is O or S; or a pharmaceutically acceptable salt thereof.
- A compound of claim 1 where R 4 is --(CH 2) m X (CH 2) n CO 2 R 5 or a pharmaceutically acceptable salt thereof.
- A compound of claim 2 wherein R 5 is alkenyl of 2-7 carbon atoms or a pharmaceutically acceptable salt thereof.
- A compound of claim 1 which is rapamycin-42-allylglutarate or a pharmaceutical salt thereof.
- A compound of claim I which is rapamycin-31-allylglutarate or a pharmaceutical salt thereof.
- A pharmaceutical composition for use as an immunosuppressive agent comprising an immunosuppressive amount of a compound having the structure ##STR14## wherein R 1, R 2, and R 3 are each, independently, hydrogen or ##STR15## with the proviso that R 1, R 2, and R 3 are not all hydrogen; R 4 is --(CH 2) m X(CH 2) n CO 2 R 5 or ##STR16## R 5 and R 6 are each, independently, hydrogen, alkenyl of 2-7 carbon atoms, alkynyl of 2-7 carbon atoms, (CH 2) p NR 9 R 10, mono-, di-, or tri-hydroxyalkyl of 1-8 carbon atoms, or aryl, which is optionally mono-, di-, or tri- substituted with a group selected from alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms of which the alkyl group is of 1-4 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, hydroxy, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, dialkylamino of 1-6 carbon atoms per alkyl group, dialkylaminoalkyl of 3-12 carbon atoms, hydroxyalkyl of 1-6 carbon atoms, alkoxyalkyl of 2-12 carbon atoms, and alkylthio of 1-6 carbon atoms wherein the above aryl group is selected from phenyl, pyridinyl, thienyl, furyl, isoxazolyl, thiazolyl, imidazolyl, pyrazinyl, pyrimidinyl, benzofuryl, benzoxazolyl, benzoisoxazolyl, benzthiazolyl, benimidazolyl, indolyl, quinolyl, isoquinolyl, thianaphthyl and benzopyranyl; X is ##STR17## R 7, R 8, R 9, and R 10 are each, independently, hydrogen or alkyl of 1-6 carbon atoms: Y is CH or N; m is 0-4; n is 0-4; p is 0-4; with the proviso that m and n are not both 0 when X is O or S; or a pharmaceutically acceptable salt thereof, and a pharmaceutical carrier.
Citations (26)
- EP0507555A1
- US3929992A
- US3993749A
- US4316885A
- US4401653A
- US4650803A
- US4885171A
- US5078999A
- US5080899A
- US5091389A
- US5100883A
- US5100899A
- US5102876A
- US5118677A
- US5118678A
- US5120842A
- US5120842B1
- US5130307A
- US5138051A
- US5151413A
- US5169851A
- US5177203A
- US5194447A
- US5221670A
- US5233036A
- WO8505031A1
Record as JSON
{
"publication_number": "US5378696A",
"country": "US",
"kind": "A",
"title": "Rapamycin esters",
"abstract": "A compound of the structure ##STR1## wherein R 1, R 2, and R 3 are each, independently, hydrogen or ##STR2## with the proviso that R 1, R 2, and R 3 are not all hydrogen; R 4 is --(CH 2) m X(CH 2) n CO 2 R 5 or ##STR3## R 5 and R 6 are each, independently, hydrogen, alkyl, alkenyl, alkynyl, (CH 2) p NR 9 R 10, mono-, di-, or tri-hydroxyalkyl, aralkyl, or aryl; ##STR4## R 7, R 8, R 9, and R 10 are each, independently, hydrogen or alkyl; Y is CH or N: m is 0-4; n is 0-4; p is 0-4; with the proviso that m and n are not both 0 when X is O or S; or a pharmaceutically acceptable salt thereof, which is by virtue of its immunosuppressive activity is useful in treating transplantation rejection, host vs. graft disease, autoimmune diseases, and diseases of inflammation, by virtue of its antitumor activity useful in treating tumors, and by virtue of its antifungal activity is useful in treating fungal infections.",
"claims": [
"1. A compound of the structure ##STR10## wherein R 1, R 2, and R 3 are each, independently, hydrogen or ##STR11## with the proviso that R 1, R 2, and R 3 are not all hydrogen; R 4 is --(CH 2) m X(CH 2) n CO 2 R 5 or ##STR12## R 5 and R 6 are each, independently, hydrogen, alkenyl of 2-7 carbon atoms, alkynyl of 2-7 carbon atoms, (CH 2) p NR 9 R 10, mono-, di-, or tri-hydroxyalkyl of 1-8 carbon atoms, or aryl, which is optionally mono-, di-, or tri- substituted with a group selected from alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms of which the alkyl group is of 1-4 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, hydroxy, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, dialkylamino of 1-6 carbon atoms per alkyl group, dialkylaminoalkyl of 3-12 carbon atoms, hydroxyalkyl of 1-6 carbon atoms, alkoxyalkyl of 2-12 carbon atoms, and alkylthio of 1-6 carbon atoms, wherein the above aryl group is selected from phenyl, pyridinyl, thienyl, furyl, isoxazolyl, thiazolyl, imidazolyl, pyrazinyl, pyrimidinyl, benzofuryl, benzoxazolyl, benzoisoxazolyl, benzthiazolyl, benimidazolyl, indolyl, quinolyl, isoquinolyl, thianaphthyl and benzopyranyl; X is ##STR13## R 7, R 8, R 9, and R 10 are each, independently, hydrogen or alkyl of 1-6 carbon atoms: Y is CH or N: m is 0-4; n is 0-4: p is 0-4; with the proviso that m and n are not both 0 when X is O or S; or a pharmaceutically acceptable salt thereof.",
"2. A compound of claim 1 where R 4 is --(CH 2) m X (CH 2) n CO 2 R 5 or a pharmaceutically acceptable salt thereof.",
"3. A compound of claim 2 wherein R 5 is alkenyl of 2-7 carbon atoms or a pharmaceutically acceptable salt thereof.",
"4. A compound of claim 1 which is rapamycin-42-allylglutarate or a pharmaceutical salt thereof.",
"5. A compound of claim I which is rapamycin-31-allylglutarate or a pharmaceutical salt thereof.",
"6. A pharmaceutical composition for use as an immunosuppressive agent comprising an immunosuppressive amount of a compound having the structure ##STR14## wherein R 1, R 2, and R 3 are each, independently, hydrogen or ##STR15## with the proviso that R 1, R 2, and R 3 are not all hydrogen; R 4 is --(CH 2) m X(CH 2) n CO 2 R 5 or ##STR16## R 5 and R 6 are each, independently, hydrogen, alkenyl of 2-7 carbon atoms, alkynyl of 2-7 carbon atoms, (CH 2) p NR 9 R 10, mono-, di-, or tri-hydroxyalkyl of 1-8 carbon atoms, or aryl, which is optionally mono-, di-, or tri- substituted with a group selected from alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms of which the alkyl group is of 1-4 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, hydroxy, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, dialkylamino of 1-6 carbon atoms per alkyl group, dialkylaminoalkyl of 3-12 carbon atoms, hydroxyalkyl of 1-6 carbon atoms, alkoxyalkyl of 2-12 carbon atoms, and alkylthio of 1-6 carbon atoms wherein the above aryl group is selected from phenyl, pyridinyl, thienyl, furyl, isoxazolyl, thiazolyl, imidazolyl, pyrazinyl, pyrimidinyl, benzofuryl, benzoxazolyl, benzoisoxazolyl, benzthiazolyl, benimidazolyl, indolyl, quinolyl, isoquinolyl, thianaphthyl and benzopyranyl; X is ##STR17## R 7, R 8, R 9, and R 10 are each, independently, hydrogen or alkyl of 1-6 carbon atoms: Y is CH or N; m is 0-4; n is 0-4; p is 0-4; with the proviso that m and n are not both 0 when X is O or S; or a pharmaceutically acceptable salt thereof, and a pharmaceutical carrier."
],
"cpc": [
"C07D 498/18",
"A61K 38/00",
"C07H 19/01",
"C07K 5/06026"
],
"assignees": [
"AMERICAN HOME PROD"
],
"filing_date": "1993-06-08",
"publication_date": "1995-01-03",
"grant_date": "1995-01-03",
"priority_date": "1990-09-19",
"application_number": "US-7385793-A",
"family_id": "46247973",
"citations": [
"EP0507555A1",
"US3929992A",
"US3993749A",
"US4316885A",
"US4401653A",
"US4650803A",
"US4885171A",
"US5078999A",
"US5080899A",
"US5091389A",
"US5100883A",
"US5100899A",
"US5102876A",
"US5118677A",
"US5118678A",
"US5120842A",
"US5120842B1",
"US5130307A",
"US5138051A",
"US5151413A",
"US5169851A",
"US5177203A",
"US5194447A",
"US5221670A",
"US5233036A",
"WO8505031A1"
]
}
Record 4,057 of 5,000 in Patents full text (MLC-0201). Request the full dataset.